Pioneer of prostate cancer: past, present and the future of FOXA1.
Pioneer of prostate cancer: past, present and the future of FOXA1.
复制标题
DOI:
10.1007/s13238-020-00786-8
复制
发表时间:
2021-01
期刊:
影响因子:
21.1
通讯作者:
He HH
中科院分区:
文献类型:
--
作者:
Teng M;Zhou S;Cai C;Lupien M;He HH
Prostate cancer is the most commonly diagnosed non-cutaneous cancers in North American men. While androgen deprivation has remained as the cornerstone of prostate cancer treatment, resistance ensues leading to lethal disease. Forkhead box A1 (FOXA1) encodes a pioneer factor that induces open chromatin conformation to allow the binding of other transcription factors. Through direct interactions with the Androgen Receptor (AR), FOXA1 helps to shape AR signaling that drives the growth and survival of normal prostate and prostate cancer cells. FOXA1 also possesses an AR-independent role of regulating epithelial-to-mesenchymal transition (EMT). In prostate cancer, mutations converge onto the coding sequence and cis-regulatory elements (CREs) of FOXA1, leading to functional alterations. In addition, FOXA1 activity in prostate cancer can be modulated post-translationally through various mechanisms such as LSD1-mediated protein demethylation. In this review, we describe the latest discoveries related to the function and regulation of FOXA1 in prostate cancer, pointing to their relevance to guide future clinical interventions.
登录
查看更多内容
影响因子:
82.9
作者:
Beltran H;Prandi D;Mosquera JM;Benelli M;Puca L;Cyrta J;Marotz C;Giannopoulou E;Chakravarthi BV;Varambally S;Tomlins SA;Nanus DM;Tagawa ST;Van Allen EM;Elemento O;Sboner A;Garraway LA;Rubin MA;Demichelis F
通讯作者:
Demichelis F
影响因子:
64.5
作者:
Cancer Genome Atlas Research Network
通讯作者:
Cancer Genome Atlas Research Network
影响因子:
5.9
作者:
Annala M;Taavitsainen S;Vandekerkhove G;Bacon JVW;Beja K;Chi KN;Nykter M;Wyatt AW
通讯作者:
Wyatt AW
影响因子:
6.6
作者:
Grossfeld, GD;Latini, DM;Carroll, PR
通讯作者:
Carroll, PR
影响因子:
--
作者:
Gao, N;Zhang, JF;Matusik, RJ
通讯作者:
Matusik, RJ